Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
0(0%)
Results Posted
30%(3 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_3
3
18%
Ph phase_2
4
24%
Ph phase_4
3
18%
Ph not_applicable
7
41%

Phase Distribution

0

Early Stage

4

Mid Stage

6

Late Stage

Phase Distribution17 total trials
Phase 2Efficacy & side effects
4(23.5%)
Phase 3Large-scale testing
3(17.6%)
Phase 4Post-market surveillance
3(17.6%)
N/ANon-phased studies
7(41.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

17

all time

Status Distribution
Active(1)
Completed(10)
Terminated(2)
Other(4)

Detailed Status

Completed10
unknown4
Terminated1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
0
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (23.5%)
Phase 33 (17.6%)
Phase 43 (17.6%)
N/A7 (41.2%)

Trials by Status

unknown424%
completed1059%
terminated16%
withdrawn16%
not_yet_recruiting16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07012785Not Applicable

Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection

Not Yet Recruiting
NCT06540209Not Applicable

Comparison of Effectiveness of Zinc Supplementation With ORS and Bacillus Clausii Versus Zinc With ORS and Saccharomyces Boulardii in Acute Watery Diarrhea in Paediatric Patients

Completed
NCT03688828Not Applicable

Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori

Completed
NCT03997279Phase 4

Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii

Unknown
NCT02637167Phase 2

GutHeart: Targeting Gut Microbiota to Treat Heart Failure

Unknown
NCT02080130Not Applicable

Efficacy of Two Probiotic Preparations in Children With Acute Diarrhoea

Withdrawn
NCT01414010Not Applicable

Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota

Completed
NCT01473368Not Applicable

Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota

Completed
NCT01609660Phase 4

Impact of Probiotics on the Intestinal Microbiota

Completed
NCT01143272Phase 3

Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea

Terminated
NCT01895530Not Applicable

Impact of Probiotics in Modulation of Intestinal Microbiota

Completed
NCT01762748Phase 2

Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant

Completed
NCT00589771Phase 3

Saccharomyces Boulardii in Irritable Bowel Syndrome

Completed
NCT01500343Phase 2

A Pilot Study of Probiotic Saccharomyces Boulardii Use in Chronic Heart Failure Patients. Estudo PROICA

Completed
NCT01315821Phase 3

Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants

Unknown
NCT00543478Phase 4

Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome

Unknown
NCT00002088Phase 2

Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial

Completed

All 17 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
17